Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Initially developed by Novo Nordisk in the 1990s, Ipamorelin is a pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) selective agonist of the GHS-R1a receptor (ghrelin receptor), responsible for stimulating pulsatile growth hormone secretion without the cross-side effects characteristic of non-selective GHRPs
Thats the question Purdues Bruce Hamaker is asking
[PMID: 37808605] PubMed record related to this compound for laboratory literature review
Viruses 10, 392
Product Specifications Research Overview This is a single vial containing two distinct growth hormone secretagogues, CJC-1295 without DAC and Ipamorelin, supplied pre-blended at 5mg of each
US$ 23.22
US$ 23.33
US$ 21.69
US$ 29.82
